Article abstract


Nature Medicine 13, 711 - 718 (2007)
Published online: 13 May 2007 | doi:10.1038/nm1585

TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1

Ahjoku Amadi-Obi1,4, Cheng-Rong Yu1,4, Xuebin Liu1, Rashid M Mahdi1, Grace Levy Clarke2, Robert B Nussenblatt2, Igal Gery3, Yun Sang Lee1 & Charles E Egwuagu1


T-helper type 17 cells (TH17) are implicated in rodent models of immune-mediated diseases. Here we report their involvement in human uveitis and scleritis, and validate our findings in experimental autoimmune uveoretinitis (EAU), a model of uveitis. TH17 cells were present in human peripheral blood mononuclear cells (PBMC), and were expanded by interleukin (IL)-2 and inhibited by interferon (IFN)-gamma. Their numbers increased during active uveitis and scleritis and decreased following treatment. IL-17 was elevated in EAU and upregulated tumor necrosis factor (TNF)-alpha in retinal cells, suggesting a mechanism by which TH17 may contribute to ocular pathology. Furthermore, IL-27 was constitutively expressed in retinal ganglion and photoreceptor cells, was upregulated by IFN-gamma and inhibited proliferation of TH17. These findings suggest that TH1 cells may mitigate uveitis by antagonizing the TH17 phenotype through the IFN-gamma–mediated induction of IL-27 in target tissue. The finding that IL-2 promotes TH17 expansion provides explanations for the efficacy of IL-2R antibody therapy in uveitis, and suggests that antagonism of TH17 by IFN-gamma and/or IL-27 could be used for the treatment of chronic inflammation.

Top
  1. Molecular Immunology Section, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
  2. Clinical Immunology Section, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
  3. Experimental Immunology Section, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
  4. These authors contributed equally to this work.

Correspondence to: Charles E Egwuagu1 e-mail: egwuaguc@nei.nih.gov




Extra navigation

Subscribe to Nature Medicine

Subscribe

naturejobs

natureproducts


ADVERTISEMENT